included_article_id,Unnamed: 0,GDG,question_id,included_postfulltext,included_reference,author_year_format,rob
56,0,1,"1.5.1, 1.5.2",53,"Al-Jefout M, Alnawaiseh C, Saleh M, Warwar K. Anti-Müllerianhormone (AMH) new cutoff as a possible tool for thediagnosis of polycystic ovary syndrome (PCOS). J Biomed Sci Res. 2021;3(2):139. Doi: 10.36266/JBSR/139.","Al-Jefout M et al., 2021",moderate
277,1,1,1.12,60,"SIR-PETERMANN, T., VANTMAN, N., CONCHA, F., ECHIBURU, B., PEREIRA, C., DE GUEVARA, A. L., CRISOSTO, N. R., PEREZ-BRAVO, F. A. & SANTOS, J. L. 2014. Metabolic Profile and Eating Behavior Score in Prepubertal and Early Pubertal Sons of Women with Polycystic Ovary Syndrome. Endocr. Rev., 35, 2.","SIR-PETERMANN et al., 2014",moderate
282,2,1,1.12,60,"Leblanc, S. H., Leblanc, S., Battista, M. C., Geller, D. H., & Baillargeon, J. P. (2016). Evolution of metabolic alterations 5 years after peri-pubertal years in young girls genetically predisposed to polycystic ovary syndrome compared to age-matched control girls. Endocrine Reviews, 37(2 Supplement 1). doi:https://dx.doi.org/10.1210/endo-meetings.2016.RE.5.SUN-156","Leblanc et al., 2016",moderate
293,3,1,1.12,60,"Lenarcik, A., Bidzinska-Speichert, B. and Tworowska-Bardzinska, U. (2011) ‘Metabolic Abnormalities in Siblings of Women with Polycystic Ovary Syndrome’, ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 20(2), pp. 165–175. ","Lenarcik et al., 2011",high
324,4,1,1.12,60,"TORCHEN, L., FOGEL, N. R., BRICKMAN, W., PAPARODIS, R. & DUNAIF, A. 2013. Persistent defects in pancreatic beta-cell function in early pubertal female relatives of women with polycystic ovary syndrome in a three year longitudinal study. Endocrine Reviews, 34.","TORCHEN et al., 2013",moderate
325,5,1,1.12,60,"TORCHEN, L. C., FOGEL, N. R., BRICKMAN, W. J., MAURAS, N. & DUNAIF, A. 2012. Beta-cell dysfunction and hyperandrogenemia in PCOS early pubertal female relatives. Endocrine Reviews, 33.","TORCHEN et al., 2012",moderate
432,6,2,2.2,80,"Ozenli, Y., Haydardedeoglu, B., Micozkadioglu, I., Simsek, E., Bulgan Kilicdag, E., & Bagis, T. (2008). Anxiety, Depression and Ways of Coping Skills by Women with Polycystic Ovary Syndrome: A Controlled Study. J Turkish-German Gynecol Assoc, 9(4), 190-194.","Ozenli et al., 2008",moderate
503,7,2,2.6.1,41,"Arif N, Khawaja S, Iqbal Q. Awareness of Polycystic Ovarian Disease: Knowledge and Presence of Presenting Symptoms. Pakistan Journal of Medical and Health Sciences. 2020;14(2):627-30.","Arif N et al., 2020",moderate
592,8,3,3.1,18,"Nasrekani ZA, Fathi M. Efficacy of 12 weeks aerobic training on body composition, aerobic power and some women‐hormones in polycystic ovary syndrome infertile women. Iranian Journal of Obstetrics, Gynecology and Infertility 2016;19(5):1‐10.","Nasrekani ZA et al., 2016",high
626,9,3,3.5,70,"Alipouri, B., Roohelhami, E., Shahrdami, F., & Rashidkhani, B. (2019). Dietary glycemic index/glycemic load and their relationship with inflammatory markers in women with polycystic ovary syndrome. PROGRESS IN NUTRITION, 21, 115-121.","Alipouri et al., 2019",moderate
676,10,3,3.5,70,"Thara, C., & Divakar, S. U. M. A. (2017). Assessment of nutritional status of PCOS women in Kerala. International Journal of Applied Home Science, 4(9-10), 717-722.","Thara et al., 2017",high
702,11,4,4.2 / 4.3,85,"Aghamohammadzadeh N, Aliasgarzadeh A, Baglar L, Abdollahifard S, Bahrami A, Najafipour F, et al. Comparison of metformin and cyproteroneestrodiol compound effect on hs c-reactive protein and serum androgen levels in patients with poly cystic ovary syndrome. Pakistan journal of medical sciences. 2010;26(2):347-51.","Aghamohammadzadeh N et al., 2010",high
719,12,4,4.2 / 4.3,85,"Dorgham N, Sharobim A, Haggag H, El-Kalioby M, Dorgham D. Adding Combined Oral Contraceptives or Metformin to Laser Treatment in Polycystic Ovarian Syndrome Hirsute Patients. J Drugs Dermatol. 2021;20(3):302-6.","Dorgham N et al., 2021",high
797,13,4,4.4,111,"Karimzadeh MA, Eftekhar M, Taheripanah R, Tayebi N, Sakhavat L, Zare F. The effect of administration of metformin on lipid profile changes and insulin resistance in patients with polycystic ovary syndrome. Middle East Fertil Soc J 2007 (ROB included in last TR under Tang 2012)","Karimzadeh MA et al., 2007",high
828,14,4,4.4,111,"Aghamohammadzadeh N, Aliasgarzadeh A, Baglar L, Abdollahifard S, Bahrami A, Najafipour F, et al. Pregnancy rate in women with pcos with high lh/fsh ratio undergoing icsi. Pakistan Journal of Medical Science 2010","Aghamohammadzadeh N et al., 2010",high
972,15,4,4.8,8,"Dorgham, N.; Sharobim, A.; Haggag, H.; El-Kalioby, M.; Dorgham, D. (2021). Adding combined oral contraceptives or metformin to l aser treatment in polycystic ovarian syndrome hirsute patients.  Journal of drugs in dermatology: JDD 2021;20(3)302-306. Doi: 10.36849/JDD.2021.5652","Dorgham et al., 2021",high
1105,16,5,5.1,65,"Al Safi WG, Hassan MF. Pregnancy rate in women with pcos with high lh/fsh ratio undergoing icsi. Latin American Journal of Pharmacy. 2021;40(Special Issue):336-40.","Al Safi WG et al., 2021",moderate
108,1,1,1.6,47,"Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. Journal of Clinical Endocrinology & Metabolism. 2004;89(6):2745-2749. doi: 10.1210/jc.2003-032046","Azziz R et al., 2004",moderate
114,2,1,1.6,47,"Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. Journal of Clinical Endocrinology & Metabolism. 1998;83(9):3078-3082. doi: 10.1210/jcem.83.9.5090","Knochenhauer ES et al., 1998",moderate
119,3,1,1.6,47,"Deswal R, Dang AS, Nanda S. Prevalence of Poly Cystic Ovary Syndrome (PCOS) in North Indian women. Indian Journal of Health and Wellbeing. 2014;5(6):742-744.","Deswal R et al., 2014",high
125,4,1,1.6,47,"Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. Journal of Clinical Endocrinology & Metabolism. 2000;85(7):2434-2438. doi: 10.1210/jcem.85.7.6682","Asuncion M et al., 2000",moderate
138,5,1,1.6,47,"Salehpour S, Shirvani HE, Entezari A. Evaluation of the prevalence of polycystic ovarian syndrome among adolescent (15-18 years old) girls in Tehran during 2005-2006. International Journal of Fertility and Sterility. 2010;4(3):122-127.","Salehpour S et al., 2005",moderate
139,6,1,1.6,47,"Sharif E, Rahman S, Zia Y, Rizk NM. The frequency of polycystic ovary syndrome in young reproductive females in Qatar. Int J Womens Health. 2017;9:1-10. doi: 10.2147/IJWH.S120027","Sharif E et al., 2017",high
234,7,1,1.9.1,18,"Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:1929–1935.","Apridonidze T et al., 2005",high
311,10,1,1.12,60,"Sam S, Coviello AD, Sung YA, Legro RS, Dunaif A. Metabolic phenotype in the brothers of women with polycystic ovary syndrome. Diabetes Care. 2008 Jun;31(6):1237-41. doi: 10.2337/dc07-2190. Epub 2008 Mar 10. PMID: 18332151; PMCID: PMC2897239. (primary citation)","Sam S et al., 2008",moderate
444,13,2,2.2,80,"Tseng PH, Chiu HM, Tu CH, Wu MS, Ho HN, Chen MJ. Obesity Exacerbates Irritable Bowel Syndrome-Related Sleep and Psychiatric Disorders in Women With Polycystic Ovary Syndrome. Front Endocrinol (Lausanne). 2021 Nov 16;12:779456. doi: 10.3389/fendo.2021.779456. PMID: 34867827; PMCID: PMC8635163.","Tseng PH et al., 2021",moderate
596,15,3,3.1,18,"Saremi A, Nader, Karmali M, Kazemi M. Serum level of anti‐mullerian hormone after exercise training in women with polycystic ovary syndrome: a randomised controlled trial. Iranian Journal of Obstetrics, Gynecology and Infertility 2013;16(64):10.","Saremi A et al., 2013",high
953,18,4,4.7,29,"Khan, R.B., M. Sarosh, and S. Anwer. 2022. “Role of Myo-Inositol and D-Chiro-Inositol in Improvement of Endocrine and Clinical Parameters in Teenage Girls Affected by PCOS: A Prospective Cohort Study.” Pakistan Journal of Medical and Health Sciences 16 (1): 21–24. https://doi.org/10.53350/pjmhs2216121.
","Khan et al., 2022",high
956,19,4,4.7,29,"Nehra, J., J. Kaushal, S.R. Singhal, and V.S. Ghalaut. 2017a. “A Comparative Study of Myo Inositol versus Metformin on Biochemical Profile in Polycystic Ovarian Syndrome in Women.” International Journal of Pharmaceutical Sciences and Research 8 (4): 1664–70. https://doi.org/10.13040/IJPSR.0975-8232.8(4).1664-70. (primary citation)","Nehra et al., 2017a",high
1213,21,5,5.4,34,"Tang T, Glanville J, Hayden CJ, White D, Barth JH, Balen AH. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. Hum Reprod. 2006 Jan;21(1):80-9. doi: 10.1093/humrep/dei311. Epub 2005 Sep 30 [Tang 2006b]","Tang T et al., 2006",moderate
3,0,1,1.2,16,"Imran H. J, Dhaher S. A, Mansour M. A. A. Testosterone or Dehydroepiandrosterone Sulfate as A Biomarker for Hirsutism in Women with Polycystic Ovary Syndrome. Biomed Pharmacol J 2020;13(4). DOI: https://dx.doi.org/10.13005/bpj/2056 ","Imran H. J et al., 2020",high
8,1,1,1.2,16,"Kumar H, Halder A, Sharma M, Jain M, Kalsi AK.Dihydrotestosterone- A Potential Biomarker of Hyperandrogenaemia in Polycystic Ovary Syndrome: A Case-control Study from North IndiaJ Clin of Diagn Res.2022; 16(2):QC09-QC14. https://www.doi.org/10.7860/JCDR/2022/51169.15962 ","Kumar H et al., 2022",high
21,2,1,1.3,7,"Imran H. J, Dhaher S. A, Mansour M. A. A. Testosterone or Dehydroepiandrosterone Sulfate as A Biomarker for Hirsutism in Women with Polycystic Ovary Syndrome. Biomed Pharmacol J 2020;13(4).","Imran H. J et al., 2020",moderate
22,3,1,1.3,7,"Kumar, H., Halder, A., Sharma, M., Jain, M., & Kalsi, A. (2022). Dihydrotestosterone- A Potential Biomarker of Hyperandrogenaemia in Polycystic Ovary Syndrome: A Case-control Study from North India. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. doi: 10.7860/jcdr/2022/51169.15962","Kumar et al., 2022",moderate
54,4,1,"1.5.1, 1.5.2",53,"Agrawal, N.; Sharma, R. Correlation of anti-müllerian hormone with clinical, hormonal and ultrasonographic parameters in pcos and normo-ovulatory women: An experience of single tertiary care center. Ital J Gynaecol Obstet 2018;30(4):37-43.","Agrawal et al., 2018",moderate
57,6,1,"1.5.1, 1.5.2",53,"Al-Naffakh AS, Risan FA. Assessment of anti-Mullerian hormone and anti ovarian antibody in the sera of patients with polycystic ovarian syndrome in AL-Najaf Al-Ashraf Province. Medico-Legal Update 2020;20(1):600–8. Doi: 10.37506/v20/i1/2020/mlu/194384.","Al-Naffakh AS et al., 2020",
71,7,1,"1.5.1, 1.5.2",53,"Gabr H, Marei ES, The Relation between Anti-Mullerian Hormone with Antral Follicle Count and Ovarian Volume in Polycystic Ovary Syndrome. Arab Journal of Nuclear Sciences and Applications 2019;52(2):84-93. ","Gabr H et al., 2019",moderate
78,8,1,"1.5.1, 1.5.2",53,"Kumari A, Tiwari HC, Srivastav R. Comparative Evaluation of Diagnostic Efficacy of Serum Anti-Müllerian Hormone and Ultrasound in Polycystic Ovarian Syndrome. J South Asian Feder Obs Gynae 2018; 10 (2):98-103","Kumari A et al., 2018",moderate
85,9,1,"1.5.1, 1.5.2",53,"Okcu NT, Nazik H, Akduman AT, Uncu G. The relation between the serum anti-Mullerian hormone levels and follicle count in polycystic ovary syndrome. The European Research Journal. P -2149-3189;4;N1 doi: 10.18621/eurj.332118","Okcu NT et al., ",moderate
94,10,1,"1.5.1, 1.5.2",53,"Sharma P, Chawla R, Ahuja R, et al. Anti-Müllerian Hormone as a Surrogate Marker for Hormonal Dysfunction and Sonographic Pattern in Polycystic Ovarian Syndrome. J South Asian Feder Obst Gynae 2019;11(3):175–180. doi: 10.5005/jp-journals-10006-1674","Sharma P et al., 2019",moderate
96,11,1,"1.5.1, 1.5.2",53,"Singh S, Firdaus A, Choudhary R, Dhama V. Role of antimullerian hormone as a diagnostic tool for polycystic ovary syndrome. Int J Reprod Contracept Obstet Gynecol. 2020;9(9):3730. DOI: 10.18203/2320-1770.ijrcog20203847.","Singh S et al., 2020",low 
101,12,1,"1.5.1, 1.5.2",53,"Tunҫ S, and Ozkan B. Analysis of New Biomarkers for the Diagnosis of Polycystic Ovary Syndrome in Adolescents Ergenlerde Polikistik Over Sendromu Tanisi icin Yeni Biyobelirteclerin Analizi. The Journal of Current Pediatrics, vol. 19, no. 3, Dec. 2021, pp. 311+. Gale OneFile: Health and Medicine.","Tunҫ S et al., 2021",high
123,15,1,1.6,47,"Vidya Bharathi R, Swetha S, Neerajaa J, et al. An epidemiological survey: Effect of predisposing factors for PCOS in Indian urban and rural population. Middle East Fertility Society Journal. 2017;22(4):313-316. doi: 10.1016/j.mefs.2017.05.007","Vidya Bharathi R et al., 2017",high
143,18,1,1.6,47,"Dashti S, Latiffah Abdul L, Habibah Abdul H, et al. Prevalence of Polycystic Ovary Syndrome among Malaysian Female University Staff. Journal of Midwifery & Reproductive Health. 2019;7(1):1560-1568. doi: 10.22038/jmrh.2018.30370.1329","Dashti S et al., 2019",moderate
182,19,1,1.9.1,18,"Begum, N., Arayousuf, N., Farooq, M. S., Chowdhury, M. A. K. & Ferdous, M. Association of Impaired Glucose Tolerance and Insulin Resistance in Women with Polycystic Ovary Syndrome. Bangladesh Journal of Obstetrics and Gynecology 34(2), 93-98, doi:https://dx.doi.org/10.3329/BJOG.V34I2.58273 (2019).","Begum et al., 2019",high
186,20,1,1.9.1,18,"Fuad, Z. F. & Alobaidy, E. J. Association of hba1c levels with body mass index in a patient diagnosed with polycystic ovary syndrome. Indian Journal of Public Health Research and Development 9(7), 298-303, doi:https://dx.doi.org/10.5958/0976-5506.2018.00659.9 (2018).","Fuad et al., 2018",high
235,21,1,1.9.2,6,"Altemimi MT, Musa AK, Mansour AA. The Performance of Glycated Hemoglobin vs. Oral Glucose Tolerance Test in the Diagnosis of Glycemic Disorders among Women with Polycystic Ovary Syndrome in Southern Iraq. The Indonesian Biomedical Journal. 2021 Jun 14;13(2):178-85.","Altemimi MT et al., 2021",high
266,22,1,1.11,23,"Uehara, T., Mitsuhashi, A., & Shozu, M. (2020). The impact of pre-existing polycystic ovary syndrome on endometrial cancer recurrence. European Journal Of Gynaecological Oncology, 41(5), 668. doi: 10.31083/j.ejgo.2020.05.5038","Uehara et al., 2020",high
297,26,1,1.12,60,"Trottier, A., Battista, M. C., Carpentier, A., Simoneau-Roy, J., Geller, D., & Baillargeon, J. P. (2011). Early metabolic and endocrine perturbations in pre- or peripubertal girls with a first degree relative with polycystic ovary syndrome. Fertility and sterility, 96(3), S129-S129. doi:10.1016/j.fertnstert.2011.07.502","Trottier et al., 2011",moderate
298,27,1,1.12,60,"Trottier, A., Battista, M. C., Simoneau-Roy, J., Carpentier, A., Geller, D. H., & Baillargeon, J. P. (2011). Early metabolic and endocrine perturbations in first-degree relative adolescent girls of polycystic ovary syndrome women. Endocrine Reviews, 32(3 Meeting Abstracts). ","Trottier et al., 2011",moderate
318,28,1,1.12,60,"Sir-Petermann, T.; Angel, B.; Maliqueo, M.; Perez-Bravo, F. Glucose tolerance, insulin secretion and insulin resistance in parents of women with polycystic ovary sindrome. Diabetologia 2001;44:A86-A86.","Sir-Petermann et al., 2001",moderate
339,31,2,2.1.1 / 2.1.2,36,"Jose, S. A.; Ravi, R.; Murthy, M. K. Quality of life in women with polycystic ovarian syndrome: Requisite of clinical pharmacist intervention. Asian Journal of Pharmaceutical and Clinical Research. Conference: 3rd International Conference on Academic and Industrial Innovations: Transitions in Pharmaceutical, Medical and Biosciences, INNOPHARM 2018;11(11): 2018","Jose et al., 2018",moderate
344,32,2,2.1.1 / 2.1.2,36,"Lidaka, L.; Lazdane, G.; Kivite-Urtane, A.; Gailite, L.; Dzivite-Krisane, I.; Stokenberga, I. Health-related quality of life and binge eating among adolescent girls with PCOS. Clinical and Experimental Obstetrics and Gynecology 2019;46(5)():831-832","Lidaka et al., 2019",
374,33,2,2.2,80,"Erson Aksu, Elmas Beyazyüz, Yakup Albayrak, Nihan Potas, Ferit Durankuş, Gamze Uvaçin & Murat Beyazyüz (2019) Altered cooperativeness in patients with polycystic ovary syndrome, Psychiatry and Clinical Psychopharmacology, 29:4, 880-886, DOI: 10.1080/24750573.2019.1691357","Erson Aksu et al., 2019",low
376,34,2,2.2,80,"Altinkaya, O., Nergiz, S., Kucuk, M., & Yuksel, H. (2014). Depression and anxiety in relation with hormonal and metabolic profile in women with polycystic ovarian syndrome. Turkiye Klinikleri J Gynecol Obst, 24(3), 159-65.","Altinkaya et al., 2014",low
392,35,2,2.2,80,"Caltekin, M., Hamamci, M., Onat, T., Kirmizi, D., Baser, E., & Yalvac, E. (2021). Evaluation of Sleep Quality, Restless Legs Syndrome, Anxiety and Depression in Polycystic Ovary Syndrome. Journal Of Turkish Sleep Medicine, 3, 243-249.","Caltekin et al., 2021",moderate
408,36,2,2.2,80,"HARMANCI, H., HERGÜNER, S., & TOY, H. (2013). Polikistik Over Sendromu olan Kadınlarda Psikiyatrik Belirtiler / Psychiatric Symptoms in Women with Polycystic Ovary Syndrome. Dusunen Adam: The Journal Of Psychiatry And Neurological Sciences, 26, 157-163. doi: 10.5350/dajpn2013260205","HARMANCI et al., 2013",low
429,37,2,2.2,80,"Mukundan, A., & Jayakumari, S. (2019). RISK OF DEVELOPING DEPRESSION AND ITS IMPACT ON QUALITY OF LIFE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME - A SOUTH INDIAN SCENARIO. International Journal Of Pharmaceutical Sciences And Research, 10(6), 2956-2961.","Mukundan et al., 2019",high
441,39,2,2.2,80,"Soyupek, F., Yildiz, S., Akkus, S., Guney, M., Mungan, M., & Eris, S. (2010). The Frequency of Fibromyalgia Syndrome in Patients with Polycystic Ovary Syndrome. Journal Of Musculoskeletal Pain, 18(2), 120-126. doi: 10.3109/10582452.2010.483968","Soyupek et al., 2010",moderate
454,40,2,2.3,29,"Elkhiat, Y., Zedan, A., Mostafa, M. and Elhalwagi, A., (2015). Sexual desire in a sample of married Egyptian women with polycystic ovarian syndrome. Human Andrology. 2015; 5(3):49-57. DOI:10.1097/01.XHA.0000470182.71509.1b","Elkhiat et al., 2015",moderate
458,41,2,2.3,29,"Gateva, A. and Kamenov, Z., (2012). Sexual Function in Patients with PCOS and/or Obesity before and after Metformin Treatment. Advances in Sexual Medicine. 2012.  DOI: 10.4236/asm.2012.22005.","Gateva et al., 2012",moderate
478,42,2,2.3,29,"Thagavi, SA, Aramesh, S, Azizi-Kutenaee, M, Allan, H, Safarzadeh, T, Taheri, M, Salari, S, Khashavi & Bazarganipour, F. (2021) The influence of infertility on sexual and marital satisfaction in Iranian women with polycystic ovary syndrome: a case-control study. Middel East Fertilty Society Journal. 2021;26(2). doi.org/10.1186/s43043-020-00047-y","Thagavi et al., 2021",moderate
490,43,2,2.5,14,"Batcheller, A., Ressler, I., Sroga, J., Martinez, A., Thomas, M., Di Paola, K. (2013). Binge eating disorder in the infertile polycystic ovary syndrome patient. Fertility and Sterility, 2013.","Batcheller et al., 2013",moderate
493,44,2,2.5,14,"Lee, I., Cooney, L., Saini, S., Smith, M., Allison, K. Dokras, A. (2016). Increased risk of eating disorders in women with polycystic ovary syndrome. Fertility and Sterility, 2016.","Lee et al., 2016",moderate
497,45,2,2.5,14,"Maher, M., Sanders, A.(2018). Eating indicators in women with polycystic ovary syndrome and weight-matched controls. FASEB Journal, 2018.","Maher et al., 2018",moderate
498,46,2,2.5,14,"Lidaka, L., Lazdane, G., Kivite-Urtane, A., Gailite, L., Dzivite-Krisane, I., Stokenberga, I. (2019). Health-related quality of life and binge eating among adolescent girls with PCOS. Clinical and Experimental Obstetrics and Gynecology, 2019.","Lidaka et al., 2019",low
510,48,2,2.6.1,41,"Dutta, D., Bhattacharya, S., Khandelwal, D., Aggarwal, S., Singla, R., Surana, V., & Dhingra, A. (2020). Clinical Practice Patterns of Polycystic Ovary Syndrome Among Doctors of Different Specialtiesâ€”An Indian Perspective. US Endocrinology, 16(2), 74-79.","Dutta et al., 2020",moderate
516,49,2,2.6.1,41,"Salman AD,. Nurses--Midwifes Knowledge Concerning Polycystic Ovary Syndrome in Baghdad Hospitals. Indian Journal of Forensic Medicine & Toxicology. 2020 Oct 1;14(4).","Salman AD et al., 2020",low
553,50,2,2.6.4,28,"Crete J, Adamshick P. Managing polycystic ovary syndrome: what our patients are telling us. Journal of Holistic Nursing. 2011 Dec;29(4):256-66.","Crete J et al., 2011",low
567,51,2,2.6.4,28,"Sharma S, Mishra AJ. Tabooed disease in alienated bodies: A study of women suffering from Polycystic Ovary Syndrome (PCOS). Clinical Epidemiology and Global Health. 2018 Sep 1;6(3):130-6.","Sharma S et al., 2018",moderate
606,54,3,3.3,12,"Hosseini Marnani E., Ghadiri-Anari A., Ramezani-Jolfaie N., Mohammadi M., Abdollahi, A., Namayandeh S. M., et al. Effect of fennel supplementation along with high-protein, low-carbohydrate weight-loss diet on insulin resistance and percentage of fat and muscle mass in overweight/obese women with polycystic ovary syndrome. Journal of Functional Foods 2020 Vol. 67 Pages 103848. https://doi.org/10.1016/j.jff.2020.103848","Hosseini Marnani E. et al., 2020",high
614,55,3,3.3,12,"Panico A, Lupoli GA, Cioffi I, Zacchia G, Caldara A, Lupoli G, Contaldo F, Pasanisi F. Effects of an isocaloric low-glycemic-load diet in polycystic ovary syndrome. Nutr Ther Metab. 2014;32:85–92.","Panico A et al., 2014",high
645,57,3,3.5,70,"Gopalan U , Ghose S , Karnaboopathy R , Comparison of dietary pattern and BMI in South Indian women with PCOS and controls. Indian J Obstet Gynecol Res 2021;8(1):57-60","Gopalan U  et al., 2021",high
696,59,3,3.6,7,"Chopra, S., Zehrung, R., Shanmugam, T. A., & Choe, E. K. (2021, May). Living with uncertainty and stigma: self-experimentation and support-seeking around polycystic ovary syndrome. In Proceedings of the 2021 CHI Conference on Human Factors in Computing Systems (pp. 1-18). https://doi.org/10.1145/3411764. 3445706","Chopra et al., 2021",insufficient information
713,61,4,4.2 / 4.3,85,"Cetinkalp S, Karadeniz M, Erdogan M, Ozgen G, Saygl F, Ylmaz C. The effects of rosiglitazone, metformin, and estradiol-cyproterone acetate on lean patients with polycystic ovary syndrome. The Endocrinologist (Baltimore, Md). 2009;19(3):94-7.","Cetinkalp S et al., 2009",high
720,62,4,4.2 / 4.3,85,"El Maghraby HA, Nafee T, Guiziry D, Elnashar A. Randomized controlled trial of the effects of metformin versus combined oral contraceptives in adolescent PCOS women through a 24 month follow up period. Middle East Fertility Society journal. 2015;20(3):131-7.","El Maghraby HA et al., 2015",
743,63,4,4.2 / 4.3,85,"Kebapcilar L, Yuksel A, Bozkaya G, Taner CE, Kebapcilar AG, Bilgir O, et al. Effects of an EE/CA compared with EE/CA-metformin on serum ADMA levels in women with polycystic ovary syndrome. Central European journal of medicine. 2009;4(4):423-7.","Kebapcilar L et al., 2009",high
779,64,4,4.2 / 4.3,85,"Taheripanah R, Sepahvandi M, Entezari A, Amiri Z, Samani EN. Evaluation of serum PSA after cyproterone compound treatment compared with oral contraceptive pill in hirsute polycystic ovary syndrome patients. Middle East Fertility Society journal. 2010;15(3):159-62.","Taheripanah R et al., 2010",high
829,67,4,4.4,111,"El Maghraby HA, Nafee T, Guiziry D, Elnashar A. Randomized controlled trial of the effects of metformin versus combined oral contraceptives in adolescent PCOS women through a 24 months follow up period. Middle East Fertility Society Journal 2015 (ROB included in last TR under Al Khalifa 2016)","El Maghraby HA et al., 2015",high
845,68,4,4.4,111,"Kebapcilar, Levent; Yuksel, Arif; Bozkaya, Giray; Taner, Cuneyt Eftal; Kebapcilar, Ayse Gul; Bilgir, Oktay; Alacacioglu, Ahmet; Sari, Ismail Effects of an EE/CA compared with EE/CA-metformin on serum ADMA levels in women with polycystic ovary syndrome Central European journal of medicine 2009;4(4):423-427. ","Kebapcilar et al., 2009",high
885,69,4,4.4,111,"Cetinkalp, S., Karadeniz, M., Erdogan, M., Ozgen, G., Saygl, F. and Ylmaz, C. 2009 The effects of rosiglitazone, metformin, and estradiol‐cyproterone acetate on lean patients with polycystic ovary syndrome. Endocrinologist. 2009 ","Cetinkalp et al., 2009",high
892,70,4,4.4,111,"Ahmad J, Shukla N, Khan AR, Ahmed F, Siddiqui MA. Comparisonof metabolic effects of metformin and rosiglitazone in the man-agement of polycystic ovary syndrome (PCOS): A prospective,parallel, randomized, open‐label study.Diabetes  Metab  Syndr:  ClinRes Rev. 2008 ","Ahmad J et al., 2008",moderate
913,71,4,4.5,17,"Zheng, S., Zhang, Y., Long, T., Lu, J., Liu, X., Yan, J., . . . Wang, F. (2017). Short term monotherapy with exenatide is superior to metformin in weight loss, improving insulin resistance and inflammation in Chinese overweight/obese PCOS women. Obesity Medicine, 7, 15-20. doi:https://doi.org/10.1016/j.obmed.2017.06.003 (primary citation)","Zheng et al., 2017",high
942,72,4,4.7,29,"Angik, Riju, Shubhada S. Jajoo, C. Hariharan, and Amogh Chimote. 2017. “A Comparative Study of Metabolic and Hormonal Effects of Myoinositol vs. Metformin in Women with Polycystic Ovary Syndrome: A Randomised Controlled Trial.” International Journal of Reproduction, Contraception, Obstetrics and Gynecology; Vol 4, No 1 (2015): January-February 2015. https://www.ijrcog.org/index.php/ijrcog/article/view/1838/1588.
","Angik et al., 2017",insufficient information
946,73,4,4.7,29,"Chirania, Kishan, Sujata Misra, and Sandhya Behera. 2017. “A Randomised Clinical Trial Comparing Myoinositol and Metformin in PCOS.” International Journal of Reproduction, Contraception, Obstetrics and Gynecology; Vol 6, No 5 (2017): May 2017DO  - 10.18203/2320-1770.Ijrcog20171563. https://www.ijrcog.org/index.php/ijrcog/article/view/2671.
","Chirania et al., 2017",insufficient information
954,75,4,4.7,29,"Maria Concetta Musacchio, Vincenzo De Leo. 2013. “A Combined Treatment with Myo-Inositol and Monacolin K Improve the Androgen and Lipid Profiles of Insulin-Resistant PCOS Patients.” J Metabolic Synd 02 (02). https://doi.org/10.4172/2167-0943.1000127.","Maria Concetta Musacchio et al., 2013",moderate
957,77,4,4.7,29,"Nehra, J., J. Kaushal, S.R. Singhal, and V.S. Ghalaut., 2017b. “Comparision of Myo-Inositol versus Metformin on Anthropometric Parameters in Polycystic Ovarian Syndrome in Women.” International Journal of Pharmacy and Pharmaceutical Sciences 9 (4): 144–48. https://doi.org/10.22159/ijpps.2017v9i4.16359.","Nehra et al., 2017b",high
958,78,4,4.7,29,"Nestler, J.E., D.J. Jakubowicz, P. Reamer, R.D. Gunn, and G. Allan. 1999. “Ovulatory and Metabolic Effects of D-Chiro-Inositol in the Polycystic Ovary Syndrome.” New England Journal of Medicine 340 (17): 1314–20. https://doi.org/10.1056/NEJM199904293401703.
","Nestler et al., 1999",moderate
1016,79,4,4.10.,109,"Gupta, A.; Raina, K.; Kalkkar, T.; et al. (2009): Pregnancy outcome in women with the polycystic ovarian syndrome. JK Science 11, 2, 82-84, http://www.jkscience.org/archive/vol112/8%20Original%20Article-Pregnancy%20Outcome%20-.pdf","Gupta et al., 2009",low
1025,80,4,4.10.,109,"Nouh, A. A.; Shalaby, S. M. (2011): The predictive value of uterine blood flow in detecting the risk of adverse pregnancy outcome in patients with polycystic ovary syndrome. Middle East Fertility Society Journal 16, 4, 284-290. http://dx.doi.org/10.1016/j.mefs.2011.09.001.","Nouh et al., 2011",low
1033,81,4,4.10.,109,"Elkholi, D. G. E. Y.; Nagy, H. M. (2014): The effects of adipocytokines on the endocrino-metabolic features and obstetric outcome in pregnant obese women with polycystic ovary syndrome. Middle East Fertility Society Journal 19, 4, 293-302. http://dx.doi.org/10.1016/j.mefs.2014.02.001.","Elkholi et al., 2014",low
1103,82,5,5.1,65,"Abu-Fakher B, Al-Quobaili F, Alhalabi M. Follicular fluid antimullerian hormone (AMH) does not predict IVF outcomes in polycystic ovary syndrome patients. Middle East Fertility Society Journal. 2013;18(2):110-4.","Abu-Fakher B et al., 2013",moderate
1110,84,5,5.1,65,"Bakir VL, Karahan G. Evaluation of obesity and metabolic status in polycystic ovary syndrome in fertile and infertile groups. Zeynep Kamil Tip Bulteni. 2019;50(2):44-8.","Bakir VL et al., 2019",moderate
1226,85,5,5.5,12,"Yadav P, Singh S, Singh R, Jain M, Awasthi S, Raj P. To study the effect on fertility outcome by gonadotropins vs laparoscopic ovarian drilling in clomiphene-resistant cases of polycystic ovarian syndrome. Journal of SAFOG 2017; 9(4): 336‐340.","Yadav P et al., 2017",high
1232,86,5,5.6,6,"Sharma, M., Kriplani, A., & Agarwal, N. (2006). Laparoscopic bipolar versus unipolar ovarian drilling in infertile women with resistant polycystic ovarian syndrome: a pilot study. Journal of gynecologic surgery, 22(3), 105-111.","Sharma et al., 2006",high
1233,87,5,5.6,6,"Yadav P, Singh S, Singh R, Jain M, Awasthi S, Raj P. To study the effect on fertility outcome by gonadotropins vs laparoscopic ovarian drilling in clomiphene-resistant cases of polycystic ovarian syndrome. Journal of SAFOG 2017; 9(4): 336‐340.","Yadav P et al., 2017",high
1234,88,5,5.7.1,7,"Ashrafi, Mahnaz & Moini, Ashraf & Mohammadzadeh, Afsaneh & Ezabadi, Zahra & Zafarani, Fatemeh & Baghestani, Ahmad. (2005). A comparative study of GnRH antagonist and GnRH agonist in PCO patients undergoing IVF/ICSI cycles. Iranian Journal of Reproductive Medicine (ISSN: 1680-6433) Vol 3 Num 1. 3. ","Ashrafi et al., 2005",high
66,2,1,"1.5.1, 1.5.2",53,"Deveer M, Deveer R, Basaran O, Turkcu UO, Akbaba E, Cullu N, Turhan N, Kucuk M, Kasap B. Serum Copeptin, Pentraxin 3, Anti-Mullerian Hormone Levels With Echocardiography and Carotid Artery Intima-Media Thickness in Adolescents With Polycystic Ovary Syndrome. J Clin Med Res. 2015 Dec;7(12):989-94. doi: 10.14740/jocmr2375w. Epub 2015 Oct 23. PMID: 26566413; PMCID: PMC4625820.","Deveer M et al., 2015",moderate
150,7,1,1.6,47,"Park YJ, Shin H, Jeon S, Cho I, Kim YJ. Menstrual Cycle Patterns and the Prevalence of Premenstrual Syndrome and Polycystic Ovary Syndrome in Korean Young Adult Women. Healthcare (Basel). 2021 Jan 7;9(1):56. doi: 10.3390/healthcare9010056. PMID: 33430265; PMCID: PMC7825721.","Park YJ et al., 2021",moderate
378,10,2,2.2,80,"Annagür BB, Tazegül A, Akbaba N. Body Image, Self-Esteem and Depressive Symptomatology in Women with Polycystic Ovary Syndrome. Noro Psikiyatr Ars. 2014 Jun;51(2):129-132. doi: 10.4274/npa.y6778. Epub 2014 Jun 1. PMID: 28360612; PMCID: PMC5353087.","Annagür BB et al., 2014",moderate
401,11,2,2.2,80,"Enjezab B, Eftekhar M, Ghadiri-Anari A. Association between severity of depression and clinico-biochemical markers of polycystic ovary syndrome. Electron Physician. 2017 Nov 25;9(11):5820-5825. doi: 10.19082/5820. PMID: 29403625; PMCID: PMC5783134.","Enjezab B et al., 2017",moderate
412,12,2,2.2,80,"Hussain A, Chandel RK, Ganie MA, Dar MA, Rather YH, Wani ZA, Shiekh JA, Shah MS. Prevalence of psychiatric disorders in patients with a diagnosis of polycystic ovary syndrome in kashmir. Indian J Psychol Med. 2015 Jan-Mar;37(1):66-70. doi: 10.4103/0253-7176.150822. PMID: 25722515; PMCID: PMC4341314.","Hussain A et al., 2015",high
437,13,2,2.2,80,"Sayyah-Melli M, Alizadeh M, Pourafkary N, Ouladsahebmadarek E, Jafari-Shobeiri M, Abbassi J, Kazemi-Shishvan MA, Sedaghat K. Psychosocial Factors Associated with Polycystic Ovary Syndrome: a Case Control Study. J Caring Sci. 2015 Sep 1;4(3):225-31. doi: 10.15171/jcs.2015.023. PMID: 26464839; PMCID: PMC4591610.","Sayyah-Melli M et al., 2015",moderate
442,14,2,2.2,80,"Sulaiman MA, Al-Farsi YM, Al-Khaduri MM, Waly MI, Saleh J, Al-Adawi S. Psychological burden among women with polycystic ovarian syndrome in Oman: a case-control study. Int J Womens Health. 2017 Dec 12;9:897-904. doi: 10.2147/IJWH.S145383. PMID: 29276413; PMCID: PMC5731436.","Sulaiman MA et al., 2017",low
501,18,2,2.5,14,"Asdaq, S., Jomah, S., Hasa, R., Al-Baroundi, D., Alharbi, M., Alsubaie, S., Buhamad, M., Alyahya, B., Al-Yamani, MM. (2020). Impact of polycystic ovary syndrome on eating behavior, depression, and health related quality of life: A cross-sectional study in Riyadh. Saudi J Biol Sci, 2020.","Asdaq et al., 2020",moderate
542,19,2,2.6.1,41,"Williams S, Sheffield D, Knibb RC. â€˜Everythingâ€™s from the inside out with PCOSâ€™: Exploring womenâ€™s experiences of living with polycystic ovary syndrome and co-morbidities through Skypeâ„¢ interviews. Health psychology open. 2015 Aug 28;2(2):2055102915603051.","Williams S et al., 2015",high
562,21,2,2.6.4,28,"Kitzinger C, Willmott J. ‘The thief of womanhood’: women's experience of polycystic ovarian syndrome. Social science & medicine. 2002 Feb 1;54(3):349-61.","Kitzinger C et al., 2002",low
573,22,2,2.6.4,28,"Williams S, Sheffield D, Knibb RC. ‘Everything’s from the inside out with PCOS’: Exploring women’s experiences of living with polycystic ovary syndrome and co-morbidities through Skype™ interviews. Health psychology open. 2015 Aug 28;2(2):2055102915603051.","Williams S et al., 2015",low
598,23,3,3.1,18,"Turan V, Mutlu EK, Solmaz U, Ekin A, Tosun O, Tosun G, et al. Benefits of short‐term structured exercise in non‐overweight women with polycystic ovary syndrome: a prospective randomised controlled study. Journal of Physical Therapy Science 2015;27(7):2293‐7.","Turan V et al., 2015",high
625,25,3,3.5,70,"Ahmadi A, Akbarzadeh M, Mohammadi F, Akbari M, Jafari B, Tolide-Ie HR. Anthropometric characteristics and dietary pattern of women with polycystic ovary syndrome. Indian J Endocrinol Metab. 2013 Jul;17(4):672-6. doi: 10.4103/2230-8210.113759. PMID: 23961484; PMCID: PMC3743368.","Ahmadi A et al., 2013",low
636,26,3,3.5,70,"Cutler DA, Pride SM, Cheung AP. Low intakes of dietary fiber and magnesium are associated with insulin resistance and hyperandrogenism in polycystic ovary syndrome: A cohort study. Food Sci Nutr. 2019 Feb 27;7(4):1426-1437. doi: 10.1002/fsn3.977. PMID: 31024716; PMCID: PMC6475723.","Cutler DA et al., 2019",moderate
652,28,3,3.5,70,"Khademi A, Alleyassin A, Aghahosseini M, Tabatabaeefar L, Amini M. The Effect of Exercise in PCOS Women Who Exercise Regularly. Asian J Sports Med. 2010 Mar;1(1):35-40. doi: 10.5812/asjsm.34874. PMID: 22375190; PMCID: PMC3289164.","Khademi A et al., 2010",moderate
671,29,3,3.5,70,"Shishehgar F, Ramezani Tehrani F, Mirmiran P, Hajian S, Baghestani AR, Moslehi N. Comparison of Dietary Intake between Polycystic Ovary Syndrome Women and Controls. Glob J Health Sci. 2016 Sep 1;8(9):54801. doi: 10.5539/gjhs.v8n9p302. PMID: 27157182; PMCID: PMC5064084.","Shishehgar F et al., 2016",moderate
672,30,3,3.5,70,"Shishehgar F, Tehrani FR, Mirmiran P, Hajian S, Baghestani AR, Moslehi N. Factors Influencing Physical Activity in Women with Polycystic Ovary Syndrome in Comparison to Eumenorrheic Non Hirsute Women. Glob J Health Sci. 2016 Oct 1;8(10):56382. doi: 10.5539/gjhs.v8n10p127. PMID: 27302456.","Shishehgar F et al., 2016",low
747,32,4,4.2 / 4.3,85,"Kumar Y, Kotwal N, Singh Y, Upreti V, Somani S, Hari Kumar KVS. A randomized, controlled trial comparing the metformin, oral contraceptive pills and their combination in patients with polycystic ovarian syndrome. J Family Med Prim Care. 2018;7(3):551-6.","Kumar Y et al., 2018",moderate
834,33,4,4.4,111,"Kumar Y, Kotwal N, Singh Y, Upreti V, Somani S, Hari Kumar KV. A randomized, controlled trial comparing the metformin, oral contraceptive pills and their combination in patients with polycystic ovarian syndrome. Journal of Family Medicine and Primary Care 2018 ","Kumar Y et al., 2018",moderate
878,34,4,4.4,111,"Diri, H.; Bayram, F.; Simsek, Y.; Caliskan, Z.; Kocer, D. Comparison of Finasteride, Metformin, and Finasteride Plus Metformin in Pcos. Acta Endocrinol (Buchar) Jan-Mar 2017;13(1):84-89","Diri et al., 2017",high
890,35,4,4.4,111,"Shahebrahimi K, Jalilian N, Bazgir N, Rezaei M. Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome. Indian J Endocrinol Metab. 2016 ","Shahebrahimi K et al., 2016",high
897,36,4,4.4,111,"Steiner CA, Janez A, Jensterle M, Reisinger K, Forst T, Pfützner A. Impact of treatment with rosiglitazone or metformin on biomarkers for insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome. J Diabetes Sci Technol. 2007","Steiner CA et al., 2007",high
944,38,4,4.7,29,"Bahadur, Anupama, Hitanshi Arora, Anoosha K Ravi, Manisha Naithani, Yogesh Bahurupi, Jaya Chaturvedi, Megha Ajmani, and Rajlaxmi Mundhra. 2021. “Comparison of Clinical, Metabolic and Hormonal Effects of Metformin Versus Combined Therapy of Metformin With Myoinositol Plus D-Chiro-Inositol in Women With Polycystic Ovary Syndrome (PCOS): A Randomized Controlled Trial.” Cureus 13 (6): e15510. https://doi.org/10.7759/cureus.15510.
","Bahadur et al., 2021",moderate
1050,42,4,4.10.,109,"Wang, F.; Dai, W.; Yang, X. H.; et al. (2016): Analyses of optimal body mass index for infertile patients with either polycystic or non-polycystic ovary syndrome during assisted reproductive treatment in China. Sci 6, 34538. https://dx.doi.org/10.1038/srep34538.","Wang et al., 2016",high
1238,44,5,5.7.1,7,"Kurzawa, R.; Ciepiela, P.; Baczkowski, T.; Safranow, K.; Brelik, P. Comparison of embryological and clinical outcome in GnRH antagonist vs. GnRH agonist protocols for in vitro fertilization in PCOS non‐obese patients. A prospective randomized study. J Assist Reprod Genet 2008, 25, 365‐74","Kurzawa et al., 2008",low
